Dermatology
4 drugs are in development for Hidradenitis Suppurativa.
- Companies
- 3
- Clinical trials
- 50
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Hidradenitis Suppurativa pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| izokibep | ACELYRIN, Inc. (SLRN) |
Phase 2(3)
About this indication
Hidradenitis Suppurativa context
Dermatology·MeSH: Hidradenitis Suppurativa (D017497)
Also known as: Acne Inversas, Hidradenitides, Suppurative, Inversa, Acne, Suppurative Hidradenitis
Prevalence
1000.0 / 100K
Incidence
100.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Hidradenitis Suppurativa?
BioSniper tracks 4 drugs in development for Hidradenitis Suppurativa across 3 companies.
How many clinical trials target Hidradenitis Suppurativa?
There are 50 clinical trials targeting Hidradenitis Suppurativa tracked by BioSniper.
What is the prevalence of Hidradenitis Suppurativa?
The estimated prevalence of Hidradenitis Suppurativa is approximately 1000.0 per 100,000 population.